Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:LPA 16:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004412 AN007378 Plasma lipidomics characterization of mouse models of Down syndrome Dp16 and Dp16-2xIfnrs versus WT mice Blood Mouse Down syndrome University of Colorado Anschutz Medical Campus LC-MS
ST003393 AN005567 Free fatty acid and lysophospholipids analysis of colon in Pla2g10 knockout mice. Colon Mouse Obesity University of Tokyo LC-MS
ST003326 AN005448 Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism Liver Mouse Liver disease University of Melbourne LC-MS
ST003090 AN005055 Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B Cultured cells Mouse Rutgers University LC-MS
ST002781 AN004528 Lipidomics analysis of maternal obesity model - wild type Liver Mouse Fatty liver disease University of Bonn MS(Dir. Inf.)
ST002781 AN004528 Lipidomics analysis of maternal obesity model - wild type Liver Mouse Obesity University of Bonn MS(Dir. Inf.)
ST002455 AN004005 Organism-Wide Analysis of Sepsis Reveals Mechanisms of Systemic Inflammation Blood Mouse Sepsis University of Chicago LC-MS
ST002200 AN003602 Human Trisome Project Plasma Metabolomics v1 Blood Human Down syndrome University of Colorado Denver LC-MS
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Adipose tissue Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Brain Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Liver Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Muscle Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001745 Lipidomics analysis for aged mice liver (part-III) Adipose tissue Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001745 Lipidomics analysis for aged mice liver (part-III) Brain Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001745 Lipidomics analysis for aged mice liver (part-III) Liver Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001745 Lipidomics analysis for aged mice liver (part-III) Muscle Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001065 AN001743 Lipidomics analysis for aged mice brain cortex (part-II) Adipose tissue Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001065 AN001743 Lipidomics analysis for aged mice brain cortex (part-II) Brain Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001065 AN001743 Lipidomics analysis for aged mice brain cortex (part-II) Liver Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001065 AN001743 Lipidomics analysis for aged mice brain cortex (part-II) Muscle Mouse Takeda Pharmaceutical Company Limited LC-MS
ST000114 AN000193 SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium B-cells Human Cancer University of Kentucky GC-MS/LC-MS
ST000110 AN000183 SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) B-cells Human University of Kentucky GC-MS/LC-MS
  logo